Bioceltix S.A. (WSE:BCX)
Poland
· Delayed Price · Currency is PLN 92.90
-1.90 (-2.00%)
At close: Dec 5, 2025
Bioceltix Market Cap
Bioceltix has a market cap or net worth of 457.48 million as of December 5, 2025. Its market cap has increased by 25.54% in one year.
Market Cap
457.48M
Enterprise Value
433.64M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
92.90
Market Cap Chart
Since November 8, 2021, Bioceltix's market cap has increased from 115.04M to 457.48M, an increase of 297.68%. That is a compound annual growth rate of 40.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 457.48M | 6.05% |
| Dec 30, 2024 | 431.38M | 16.07% |
| Dec 29, 2023 | 371.65M | 179.48% |
| Dec 30, 2022 | 132.98M | -22.49% |
| Dec 30, 2021 | 171.57M | 49.14% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 5.66B |
| NEUCA | 3.70B |
| Synektik Spólka Akcyjna | 2.37B |
| Voxel | 1.40B |
| Celon Pharma | 1.14B |
| Selvita | 870.05M |
| Ryvu Therapeutics | 670.48M |
| Centrum Medyczne ENEL-MED | 509.05M |